CANC vs. XBI ETF Comparison

Comparison of Tema Oncology ETF (CANC) to SPDR S&P Biotech ETF (XBI)
CANC

Tema Oncology ETF

CANC Description

Under normal circumstances, the fund seeks to achieve its investment objective by investing at least 80% of its net assets, which include borrowings for investment purposes, in publicly listed companies that derive at least 50% of revenues from oncology. The fund is non-diversified.

Grade (RS Rating)

Last Trade

$27.91

Average Daily Volume

3,114

Number of Holdings *

43

* may have additional holdings in another (foreign) market
XBI

SPDR S&P Biotech ETF

XBI Description The investment seeks to provide investment results that, before fees and expenses, correspond generally to the total return performance of an index derived from the biotechnology segment of a U.S. total market composite index. In seeking to track the performance of the S&P Biotechnology Select Industry Index (the "index"), the fund employs a replication strategy. It generally invests substantially all, but at least 80%, of its total assets in the securities comprising the index. The index represents the biotechnology industry group of the S&P Total Market Index ("S&P TMI"). The fund is non-diversified.

Grade (RS Rating)

Last Trade

$99.27

Average Daily Volume

6,763,174

Number of Holdings *

128

* may have additional holdings in another (foreign) market
Performance
Period CANC XBI
30 Days -0.85% 1.20%
60 Days -6.56% -1.95%
90 Days -1.34% 2.92%
12 Months 24.12% 45.66%
26 Overlapping Holdings
Symbol Grade Weight in CANC Weight in XBI Overlap
ACLX B 1.69% 0.75% 0.75%
AGIO B 2.13% 0.61% 0.61%
AMGN C 5.42% 2.45% 2.45%
BPMC C 3.14% 1.51% 1.51%
CGEM F 0.83% 0.27% 0.27%
CGON F 0.55% 0.43% 0.43%
CLDX F 1.58% 0.4% 0.4%
COGT B 1.19% 0.21% 0.21%
CRSP C 2.22% 1.5% 1.5%
DAWN A 1.87% 0.3% 0.3%
EXAS A 2.27% 2.77% 2.27%
EXEL A 2.33% 0.96% 0.96%
GILD A 4.36% 2.72% 2.72%
IDYA F 0.89% 0.57% 0.57%
INCY A 3.38% 2.65% 2.65%
JANX A 1.42% 0.52% 0.52%
MRNA F 0.94% 2.02% 0.94%
NRIX B 0.8% 0.35% 0.35%
NTLA F 2.05% 0.78% 0.78%
NUVL D 2.03% 0.61% 0.61%
ORIC D 0.75% 0.09% 0.09%
RCUS F 0.72% 0.22% 0.22%
REGN F 5.42% 2.11% 2.11%
RLAY F 0.76% 0.17% 0.17%
RVMD A 3.83% 1.24% 1.24%
SWTX D 1.21% 0.6% 0.6%
CANC Overweight 17 Positions Relative to XBI
Symbol Grade Weight
ARGX A 3.87%
ILMN A 3.83%
MRK F 2.8%
MREO D 2.78%
BGNE C 2.58%
NVS D 2.18%
GMAB F 1.94%
LEGN F 1.81%
LNTH C 1.65%
MRUS C 1.42%
GH D 1.38%
SDGR F 1.06%
BCYC D 0.93%
BNTX B 0.93%
IMCR F 0.67%
TERN D 0.63%
ARVN C 0.48%
CANC Underweight 102 Positions Relative to XBI
Symbol Grade Weight
ALNY C -2.87%
UTHR A -2.69%
SRPT D -2.69%
ABBV A -2.5%
VRTX D -2.5%
INSM D -2.49%
NBIX C -2.43%
BIIB F -2.42%
NTRA B -2.42%
VKTX A -2.34%
BMRN F -2.13%
CYTK F -1.73%
HALO B -1.44%
MDGL A -1.38%
RNA C -1.38%
KRYS C -1.21%
TGTX A -1.2%
IONS F -1.17%
ROIV D -1.16%
PCVX C -1.1%
ALKS F -1.09%
IOVA B -0.98%
ADMA B -0.94%
BBIO D -0.91%
GERN C -0.88%
CRNX B -0.87%
TWST F -0.87%
APLS F -0.84%
DYN F -0.82%
RARE D -0.82%
FOLD B -0.71%
IMVT F -0.7%
PTCT B -0.66%
RXRX F -0.65%
PTGX B -0.64%
BEAM F -0.62%
ACAD F -0.62%
NVAX F -0.57%
ARWR F -0.54%
ARDX D -0.51%
MIRM B -0.5%
SNDX F -0.49%
KYMR C -0.49%
SRRK B -0.49%
VERA A -0.48%
RYTM D -0.48%
DNLI C -0.47%
BCRX A -0.46%
VCYT A -0.45%
DVAX A -0.44%
AKRO A -0.4%
CPRX A -0.4%
MYGN F -0.38%
KROS A -0.36%
RCKT F -0.35%
VCEL D -0.35%
ARQT D -0.35%
SMMT C -0.33%
VRDN B -0.32%
MNKD A -0.31%
IRON D -0.26%
TVTX B -0.25%
KURA F -0.24%
CDNA D -0.24%
IRWD F -0.24%
HUMA D -0.22%
APLT A -0.22%
ANAB F -0.21%
XNCR A -0.21%
ANNX B -0.2%
ARCT F -0.2%
SPRY B -0.2%
VIR B -0.2%
REPL B -0.19%
SANA F -0.19%
EBS B -0.19%
VERV C -0.18%
CDMO C -0.18%
SAGE F -0.17%
PRTA F -0.16%
ALT D -0.16%
OLMA F -0.16%
ETNB D -0.15%
STOK C -0.15%
IMNM F -0.15%
CELC D -0.14%
CCCC F -0.13%
ALLO D -0.13%
FDMT F -0.12%
OCGN F -0.11%
RGNX F -0.11%
AVXL A -0.11%
MDXG C -0.1%
FATE F -0.1%
SVRA D -0.09%
ERAS C -0.09%
SCLX D -0.08%
YMAB A -0.08%
KALV D -0.08%
ITOS F -0.07%
ABUS D -0.07%
ALEC D -0.05%
Compare ETFs